SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

__________________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 15, 2016

THE FEMALE HEALTH COMPANY 
(Exact name of registrant as specified in its charter)

Wisconsin
(State or other jurisdiction of incorporation)

1-13602
  
39-1144397
(Commission File Number)
  
(I.R.S. Employer I.D. Number)

515 North State Street
Suite 2225
Chicago, Illinois
  
 
 
60654
(Address of Principal Executive Offices)
  
(Zip Code)

312-595-9123
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o           Written communications pursuant to Rule 425 under the Securities Act
(17 CFR230.425)

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 


Item 5.07                      Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders of the Company was held on March 15, 2016.  A total of 29,030,499 shares of common stock were eligible to vote at the Annual Meeting.  The matters voted on at the Annual Meeting were as follows:

1.           Election of Directors:

The following individuals were nominated for election to the Board of Directors for terms that expire at the next annual meeting of shareholders.  All of the nominated directors were elected.  The results of the vote on the election of directors were as follows:

 
Name
Votes For
  
Votes  Withheld
Broker  Non-Votes
  
David R. Bethune
  12,394,489    964,760  12,216,516  
Donna Felch
  12,551,122    808,127  12,216,516  
Mary Margaret Frank, Ph.D.
  12,458,047    901,202  12,216,516  
William R. Gargiulo, Jr.
  12,198,764    1,160,485  12,216,516  
Andrew S. Love
  12,432,388    926,861  12,216,516  
Sharon Meckes
  12,471,362    887,887  12,216,516  
O.B. Parrish
  12,534,814    824,435  12,216,516  

2.           Ratification of Auditors:

The shareholders voted to ratify the appointment by the Company's Audit Committee of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2016.
 
 
Votes For  Votes Against  Abstentions  Broker Non-Votes
 24,669,185  767,591  108,989  0
 
 

 


 
 
 
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

THE FEMALE HEALTH COMPANY
Date:  March 16, 2016
BY   /s/ Michele Greco                                                                                      
Michele Greco, Executive Vice President and Chief Financial Officer